Exploring the Clinical Presentation, Course, and Burden of Disease in Generalized Pustular Psoriasis [Podcast]

References

• Navarini AA, Burden AD, Capon F, et al. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol. 2017;31(11):1792–1799. doi:10.1111/jdv.14386
   PubMed Web of Science ®Google Scholar
• Fujita H, Terui T, Hayama K, et al. Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP. J Dermatol. 2018;45(11):1235–1270. doi:10.1111/1346-8138.14523
   PubMed Web of Science ®Google Scholar
• Zheng M, Jullien D, Eyerich K. The prevalence and disease characteristics of generalized pustular psoriasis. Am J Clin Dermatol. 2022;23(Suppl 1):5–12. doi:10.1007/s40257-021-00664-x
   PubMed Web of Science ®Google Scholar
• Ohkawara A, Yasuda H, Kobayashi H, et al. Generalized pustular psoriasis in Japan: two distinct groups formed by differences in symptoms and genetic background. Acta Derm Venereol. 1996;76(1):68–71. doi:10.2340/00015555766871
   PubMed Web of Science ®Google Scholar
• Augey F, Renaudier P, Nicolas JF. Generalized pustular psoriasis (Zumbusch): a French epidemiological survey. Eur J Dermatol. 2006;16(6):669–673.
   PubMed Web of Science ®Google Scholar
• Tosukhowong T, Kiratikanon S, Wonglamsam P, et al. Epidemiology and clinical features of pustular psoriasis: A 15-year retrospective cohort. J Dermatol. 2021;48(12):1931–1935.
   PubMed Web of Science ®Google Scholar
• Choon SE, Lai NM, Mohammad NA, Nanu NM, Tey KE, Chew SF. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol. 2014;53(6):676–684. doi:10.1111/ijd.12070
   PubMed Web of Science ®Google Scholar
• Marrakchi S, Puig L. Pathophysiology of generalized pustular psoriasis. Am J Clin Dermatol. 2022;23(Suppl 1):13–19. doi:10.1007/s40257-021-00655-y
   PubMed Web of Science ®Google Scholar
• Choon SE, Navarini AA, Pinter A. Clinical course and characteristics of generalized pustular psoriasis. Am J Clin Dermatol. 2022;23(Suppl 1):21–29. doi:10.1007/s40257-021-00654-z
   PubMed Web of Science ®Google Scholar
• Gooderham MJ, Van Voorhees AS, Lebwohl MG. An update on generalized pustular psoriasis. Expert Rev Clin Immunol. 2019;15(9):907–919. doi:10.1080/1744666X.2019.1648209
   PubMed Web of Science ®Google Scholar
• Kharawala S, Golembesky AK, Bohn RL, Esser D. The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review. Expert Rev Clin Immunol. 2020;16(3):239–252. doi:10.1080/1744666X.2019.1708193
   PubMed Web of Science ®Google Scholar
• Bachelez H, Choon SE, Marrakchi S, et al. Inhibition of the interleukin-36 pathway for the treatment of generalized pustular psoriasis. N Engl J Med. 2019;380(10):981–983. doi:10.1056/NEJMc1811317
   PubMed Web of Science ®Google Scholar
• Burden AD, Choon SE, Gottlieb AB, Navarini AA, Warren RB. Clinical disease measures in generalized pustular psoriasis. Am J Clin Dermatol. 2022;23(Suppl 1):39–50. doi:10.1007/s40257-021-00653-0
   PubMed Web of Science ®Google Scholar
• Crowley JJ, Pariser DM, Yamauchi PS. A brief guide to pustular psoriasis for primary care providers. Postgrad Med. 2021;133(3):330–344. doi:10.1080/00325481.2020.1831315
   PubMed Web of Science ®Google Scholar
• Trivedi MK, Vaughn AR, Murase JE. Pustular psoriasis of pregnancy: current perspectives. Int J Womens Health. 2018;10:109–115. doi:10.2147/IJWH.S125784
   PubMed Web of Science ®Google Scholar
• Seishima M, Fujii K, Mizutani Y. Generalized pustular psoriasis in pregnancy: current and future treatments. Am J Clin Dermatol. 2022;23(5):661–671. doi:10.1007/s40257-022-00698-9
   PubMed Web of Science ®Google Scholar
• Stadler PC, Oschmann A, Kerl-French K, et al. Acute generalized exanthematous pustulosis: clinical characteristics, pathogenesis, and management. Dermatology. 2023;239(3):328–333. doi:10.1159/000529218
   PubMed Web of Science ®Google Scholar
• Reisner DV, Johnsson FD, Kotowsky N, Brunette S, Valdecantos W, Eyerich K. Impact of generalized pustular psoriasis from the perspective of people living with the condition: results of an online survey. Am J Clin Dermatol. 2022;23(Suppl 1):65–71. doi:10.1007/s40257-021-00663-y
   PubMed Web of Science ®Google Scholar
• Miyachi H, Konishi T, Kumazawa R, et al. Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan. J Am Acad Dermatol. 2022;86(6):1266–1274. doi:10.1016/j.jaad.2021.06.008
   PubMed Web of Science ®Google Scholar
• Cockerill C. Pustular psoriasis. Medscape; 2021. Available from: https://emedicine.medscape.com/article/1108220-overview. Accessed July 17, 2023.
   Google Scholar
• Prinz JC, Choon SE, Griffiths CEM, et al. Prevalence, comorbidities and mortality of generalized pustular psoriasis: A literature review. J Eur Acad Dermatol Venereol. 2023;37(2):256–273. doi:10.1111/jdv.18720
   PubMed Web of Science ®Google Scholar
• Hanna ML, Singer D, Valdecantos WC. Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States. Curr Med Res Opin. 2021;37(5):735–742. doi:10.1080/03007995.2021.1894108
   PubMed Web of Science ®Google Scholar
• Okubo Y, Kotowsky N, Gao R, Saito K, Morita A. Clinical characteristics and health-care resource utilization in patients with generalized pustular psoriasis using real-world evidence from the Japanese Medical Data Center database. J Dermatol. 2021;48(11):1675–1687. doi:10.1111/1346-8138.16084
   PubMed Web of Science ®Google Scholar
• Lebwohl M, Medeiros RA, Mackey RH, et al. The disease burden of generalized pustular psoriasis: real-world evidence from CorEvitas’ Psoriasis Registry. J Psoriasis Psoriatic Arthritis. 2022;7(2):71–78. doi:10.1177/24755303221079814
   Google Scholar
• Lofvendahl S, Norlin JM, Schmitt-Egenolf M. Economic burden of generalized pustular psoriasis In Sweden: a population-based register study. Psoriasis. 2022;12:89–98. doi:10.2147/PTT.S359011
   PubMed Web of Science ®Google Scholar
• Krueger J, Puig L, Thaçi D. Treatment options and goals for patients with generalized pustular psoriasis. Am J Clin Dermatol. 2022;23(Suppl 1):51–64. doi:10.1007/s40257-021-00658-9
   PubMed Web of Science ®Google Scholar
• Boehringer Ingelheim. FDA approves the first treatment option for generalized pustular psoriasis flares in adults; 2022. Available from: https://www.boehringer-ingelheim.us/press-release/fda-approves-first-treatment-option-generalized-pustular-psoriasis-flares-adults. Accessed September 28, 2022.
   Google Scholar
• Boehringer Ingelheim. European Commission approves SPEVIGO® (spesolimab) for generalized pustular psoriasis flares; 2022. Available from: https://www.boehringer-ingelheim.com/human-health/skin-diseases/gpp/european-commission-approves-spevigo-spesolimab-generalized. Accessed January 24, 2023.
   Google Scholar
• AnaptysBio. Long-Term Safety and Efficacy of Imsidolimab (ANB019) in Subjects With Generalized Pustular Psoriasis (GEMINI 2); 2022. Available from: https://clinicaltrials.gov/study/NCT05366855?tab=table. Accessed July 18, 2023.
   Google Scholar